4//SEC Filing
WP X Finance, L.P. 4
Accession 0001628280-19-004178
CIK 0001397702other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 9:58 PM ET
Size
170.7 KB
Accession
0001628280-19-004178
Insider Transaction Report
Form 4
Warburg Pincus Partners, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2019-04-08+13,079,728→ 13,099,629 total - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,291→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (34,291 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,361→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (34,361 underlying) - Other
Series C Preferred Stock
2019-04-08−20,974→ 47,678 total→ Common Stock (20,974 underlying) - Sale
Common Stock
2019-04-08$20.00/sh−900,000$18,000,000→ 12,199,629 total - Exercise of In-Money
Series C Preferred Stock
2019-04-08+68,652→ 68,652 total→ Common Stock (68,652 underlying) - Conversion
Series C Preferred Stock
2019-04-08−5,904,180→ 0 total→ Common Stock (5,904,180 underlying) - Conversion
Series B Preferred Stock
2019-04-08−5,637,492→ 0 total→ Common Stock (5,637,492 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,071,902→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (1,071,902 underlying) - Exercise of In-Money
Series C Preferred Stock
2019-04-08+2,145,974→ 2,145,974 total→ Common Stock (2,145,974 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,074,072→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (1,074,072 underlying) - Other
Series C Preferred Stock
2019-04-08−655,596→ 1,490,378 total→ Common Stock (655,596 underlying) - Conversion
Series C Preferred Stock
2019-04-08−1,538,056→ 0 total→ Common Stock (1,538,056 underlying)
WP X Finance, L.P.
10% Owner
Transactions
- Exercise of In-Money
Series C Preferred Stock
2019-04-08+2,145,974→ 2,145,974 total→ Common Stock (2,145,974 underlying) - Sale
Common Stock
2019-04-08$20.00/sh−900,000$18,000,000→ 12,199,629 total - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,361→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (34,361 underlying) - Exercise of In-Money
Series C Preferred Stock
2019-04-08+68,652→ 68,652 total→ Common Stock (68,652 underlying) - Other
Series C Preferred Stock
2019-04-08−20,974→ 47,678 total→ Common Stock (20,974 underlying) - Conversion
Common Stock
2019-04-08+13,079,728→ 13,099,629 total - Conversion
Series B Preferred Stock
2019-04-08−5,637,492→ 0 total→ Common Stock (5,637,492 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,074,072→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (1,074,072 underlying) - Conversion
Series C Preferred Stock
2019-04-08−5,904,180→ 0 total→ Common Stock (5,904,180 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,291→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (34,291 underlying) - Other
Series C Preferred Stock
2019-04-08−655,596→ 1,490,378 total→ Common Stock (655,596 underlying) - Conversion
Series C Preferred Stock
2019-04-08−1,538,056→ 0 total→ Common Stock (1,538,056 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,071,902→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (1,071,902 underlying)
WPX GP, L.P.
10% Owner
Transactions
- Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,071,902→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (1,071,902 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,291→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (34,291 underlying) - Sale
Common Stock
2019-04-08$20.00/sh−900,000$18,000,000→ 12,199,629 total - Exercise of In-Money
Series C Preferred Stock
2019-04-08+2,145,974→ 2,145,974 total→ Common Stock (2,145,974 underlying) - Exercise of In-Money
Series C Preferred Stock
2019-04-08+68,652→ 68,652 total→ Common Stock (68,652 underlying) - Other
Series C Preferred Stock
2019-04-08−655,596→ 1,490,378 total→ Common Stock (655,596 underlying) - Conversion
Series C Preferred Stock
2019-04-08−1,538,056→ 0 total→ Common Stock (1,538,056 underlying) - Conversion
Series C Preferred Stock
2019-04-08−5,904,180→ 0 total→ Common Stock (5,904,180 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,074,072→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (1,074,072 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,361→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (34,361 underlying) - Other
Series C Preferred Stock
2019-04-08−20,974→ 47,678 total→ Common Stock (20,974 underlying) - Conversion
Common Stock
2019-04-08+13,079,728→ 13,099,629 total - Conversion
Series B Preferred Stock
2019-04-08−5,637,492→ 0 total→ Common Stock (5,637,492 underlying)
Transactions
- Sale
Common Stock
2019-04-08$20.00/sh−900,000$18,000,000→ 12,199,629 total - Conversion
Series C Preferred Stock
2019-04-08−5,904,180→ 0 total→ Common Stock (5,904,180 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,074,072→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (1,074,072 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,291→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (34,291 underlying) - Conversion
Common Stock
2019-04-08+13,079,728→ 13,099,629 total - Exercise of In-Money
Series C Preferred Stock
2019-04-08+2,145,974→ 2,145,974 total→ Common Stock (2,145,974 underlying) - Exercise of In-Money
Series C Preferred Stock
2019-04-08+68,652→ 68,652 total→ Common Stock (68,652 underlying) - Other
Series C Preferred Stock
2019-04-08−655,596→ 1,490,378 total→ Common Stock (655,596 underlying) - Other
Series C Preferred Stock
2019-04-08−20,974→ 47,678 total→ Common Stock (20,974 underlying) - Conversion
Series C Preferred Stock
2019-04-08−1,538,056→ 0 total→ Common Stock (1,538,056 underlying) - Conversion
Series B Preferred Stock
2019-04-08−5,637,492→ 0 total→ Common Stock (5,637,492 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,071,902→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (1,071,902 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,361→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (34,361 underlying)
WPP GP LLC
10% Owner
Transactions
- Conversion
Common Stock
2019-04-08+13,079,728→ 13,099,629 total - Conversion
Series C Preferred Stock
2019-04-08−1,538,056→ 0 total→ Common Stock (1,538,056 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,071,902→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (1,071,902 underlying) - Sale
Common Stock
2019-04-08$20.00/sh−900,000$18,000,000→ 12,199,629 total - Other
Series C Preferred Stock
2019-04-08−20,974→ 47,678 total→ Common Stock (20,974 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,361→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (34,361 underlying) - Conversion
Series B Preferred Stock
2019-04-08−5,637,492→ 0 total→ Common Stock (5,637,492 underlying) - Conversion
Series C Preferred Stock
2019-04-08−5,904,180→ 0 total→ Common Stock (5,904,180 underlying) - Exercise of In-Money
Series C Preferred Stock
2019-04-08+2,145,974→ 2,145,974 total→ Common Stock (2,145,974 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,074,072→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (1,074,072 underlying) - Exercise of In-Money
Series C Preferred Stock
2019-04-08+68,652→ 68,652 total→ Common Stock (68,652 underlying) - Other
Series C Preferred Stock
2019-04-08−655,596→ 1,490,378 total→ Common Stock (655,596 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,291→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (34,291 underlying)
Warburg Pincus X LLC
10% Owner
Transactions
- Conversion
Common Stock
2019-04-08+13,079,728→ 13,099,629 total - Conversion
Series B Preferred Stock
2019-04-08−5,637,492→ 0 total→ Common Stock (5,637,492 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,071,902→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (1,071,902 underlying) - Sale
Common Stock
2019-04-08$20.00/sh−900,000$18,000,000→ 12,199,629 total - Conversion
Series C Preferred Stock
2019-04-08−5,904,180→ 0 total→ Common Stock (5,904,180 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,074,072→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (1,074,072 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,361→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (34,361 underlying) - Exercise of In-Money
Series C Preferred Stock
2019-04-08+68,652→ 68,652 total→ Common Stock (68,652 underlying) - Other
Series C Preferred Stock
2019-04-08−655,596→ 1,490,378 total→ Common Stock (655,596 underlying) - Other
Series C Preferred Stock
2019-04-08−20,974→ 47,678 total→ Common Stock (20,974 underlying) - Conversion
Series C Preferred Stock
2019-04-08−1,538,056→ 0 total→ Common Stock (1,538,056 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,291→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (34,291 underlying) - Exercise of In-Money
Series C Preferred Stock
2019-04-08+2,145,974→ 2,145,974 total→ Common Stock (2,145,974 underlying)
WARBURG PINCUS X PARTNERS, L.P.
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2019-04-08−5,637,492→ 0 total→ Common Stock (5,637,492 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,074,072→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (1,074,072 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,361→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (34,361 underlying) - Exercise of In-Money
Series C Preferred Stock
2019-04-08+68,652→ 68,652 total→ Common Stock (68,652 underlying) - Conversion
Common Stock
2019-04-08+13,079,728→ 13,099,629 total - Conversion
Series C Preferred Stock
2019-04-08−5,904,180→ 0 total→ Common Stock (5,904,180 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,071,902→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (1,071,902 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,291→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (34,291 underlying) - Exercise of In-Money
Series C Preferred Stock
2019-04-08+2,145,974→ 2,145,974 total→ Common Stock (2,145,974 underlying) - Other
Series C Preferred Stock
2019-04-08−655,596→ 1,490,378 total→ Common Stock (655,596 underlying) - Other
Series C Preferred Stock
2019-04-08−20,974→ 47,678 total→ Common Stock (20,974 underlying) - Sale
Common Stock
2019-04-08$20.00/sh−900,000$18,000,000→ 12,199,629 total - Conversion
Series C Preferred Stock
2019-04-08−1,538,056→ 0 total→ Common Stock (1,538,056 underlying)
Warburg Pincus X, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2019-04-08+13,079,728→ 13,099,629 total - Conversion
Series B Preferred Stock
2019-04-08−5,637,492→ 0 total→ Common Stock (5,637,492 underlying) - Other
Series C Preferred Stock
2019-04-08−20,974→ 47,678 total→ Common Stock (20,974 underlying) - Sale
Common Stock
2019-04-08$20.00/sh−900,000$18,000,000→ 12,199,629 total - Conversion
Series C Preferred Stock
2019-04-08−5,904,180→ 0 total→ Common Stock (5,904,180 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,071,902→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (1,071,902 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,074,072→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (1,074,072 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,291→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (34,291 underlying) - Exercise of In-Money
Series C Preferred Stock
2019-04-08+2,145,974→ 2,145,974 total→ Common Stock (2,145,974 underlying) - Other
Series C Preferred Stock
2019-04-08−655,596→ 1,490,378 total→ Common Stock (655,596 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,361→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (34,361 underlying) - Exercise of In-Money
Series C Preferred Stock
2019-04-08+68,652→ 68,652 total→ Common Stock (68,652 underlying) - Conversion
Series C Preferred Stock
2019-04-08−1,538,056→ 0 total→ Common Stock (1,538,056 underlying)
Warburg Pincus Partners GP LLC
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2019-04-08−5,637,492→ 0 total→ Common Stock (5,637,492 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,074,072→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (1,074,072 underlying) - Exercise of In-Money
Series C Preferred Stock
2019-04-08+2,145,974→ 2,145,974 total→ Common Stock (2,145,974 underlying) - Exercise of In-Money
Series C Preferred Stock
2019-04-08+68,652→ 68,652 total→ Common Stock (68,652 underlying) - Other
Series C Preferred Stock
2019-04-08−655,596→ 1,490,378 total→ Common Stock (655,596 underlying) - Conversion
Common Stock
2019-04-08+13,079,728→ 13,099,629 total - Sale
Common Stock
2019-04-08$20.00/sh−900,000$18,000,000→ 12,199,629 total - Other
Series C Preferred Stock
2019-04-08−20,974→ 47,678 total→ Common Stock (20,974 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,291→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (34,291 underlying) - Conversion
Series C Preferred Stock
2019-04-08−1,538,056→ 0 total→ Common Stock (1,538,056 underlying) - Conversion
Series C Preferred Stock
2019-04-08−5,904,180→ 0 total→ Common Stock (5,904,180 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−1,071,902→ 0 totalExercise: $6.11Exp: 2022-08-07→ Common Stock (1,071,902 underlying) - Exercise of In-Money
Series C Preferred Stock Warrant (Right to buy)
2019-04-08−34,361→ 0 totalExercise: $6.11Exp: 2023-10-13→ Common Stock (34,361 underlying)
Footnotes (20)
- [F1]The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
- [F10]All of the shares subject to the warrant are fully exercisable as of the date hereof.
- [F11]This warrant is held by WP X Finance.
- [F12]WP X Finance exercised a warrant to purchase 1,074,072 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WP X Finance paid the exercise price on a cashless basis, resulting in the Issuer withholding 328,129 of the warrant shares to pay the exercise price and issued to WP X Finance the remaining 745,943 shares.
- [F13]WPXP exercised a warrant to purchase 34,291 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WPXP paid the exercise price on a cashless basis, resulting in the Issuer withholding 10,476 of the warrant shares to pay the exercise price and issued to WPXP the remaining 23,815 shares.
- [F14]This warrant is held by WPXP.
- [F15]WPXP exercised a warrant to purchase 34,361 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WPXP paid the exercise price on a cashless basis, resulting in the Issuer withholding 10,498 of the warrant shares to pay the exercise price and issued to WPXP the remaining 23,863 shares.
- [F16]These shares are held by WP X Finance.
- [F17]These shares are held by WPXP.
- [F18]These shares are comprised of 327,467 shares and 328,129 shares withheld by the Issuer pursuant to the net exercise of warrants, as detailed in footnotes (9) and (12).
- [F19]These shares are comprised of 10,476 shares and 10,498 shares withheld by the Issuer pursuant to the net exercise of warrants, as detailed in footnotes (13) and (15).
- [F2]12,693,546 of these shares are held by WP X Finance, L.P. ("WP X Finance") and 406,083 of these shares are held by Warburg Pincus X Partners, L.P. ("WPXP"). The total of 13,099,629 shares beneficially owned is comprised of (i) 19,901 shares of Common Stock held prior to the date hereof (ii) 5,637,492 shares of Common Stock issued upon conversion of Series B Preferred Stock held prior to the date hereof, (iii) 5,904,180 shares of Common Stock issued upon conversion of Series C Preferred Stock held prior to the date hereof, and (iv) 1,538,056 shares of Common Stock issued upon conversion of Series C Preferred Stock issued pursuant to the net exercise of warrants, as detailed in footnotes (9), (12), (13) and (15).
- [F20]Prior to conversion to Common Stock, these shares are comprised of 1,490,378 shares held by WPX Finance and 47,678 shares held by WPXP.
- [F3]WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. Warburg Pincus X, L.P., a Delaware limited partnership ("WPX LP"), is the general partner of WPX and WPXP. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP LP"), is the general partner of WPX LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP LP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners.
- [F4](continuation from footnote 3) Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Charles R. Kaye and Joseph P. Landy are each Managing General Partners of WP and may each be deemed to control the Warburg Pincus entities. Messrs. Kaye and Landy disclaim beneficial ownership of all shares held by the Warburg Pincus entities.
- [F5]872,100 shares were sold by WP X Finance, and 27,900 shares were sold by WPXP, each in connection with the exercise of the underwriter's overallotment option pursuant to the Issuer's initial public offering of Common Stock.
- [F6]11,821,446 of these shares are held by WP X Finance and 378,183 of these shares are held by WPXP.
- [F7]5,462,731 of these shares are held by WP X Finance and 174,761 of these shares are held by WPXP.
- [F8]5,721,152 of these shares are held by WP X Finance and 183,028 of these shares are held by WPXP.
- [F9]WP X Finance exercised a warrant to purchase 1,071,902 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WP X Finance paid the exercise price on a cashless basis, resulting in the Issuer withholding 327,467 of the warrant shares to pay the exercise price and issued to WP X Finance the remaining 744,435 shares.
Issuer
Silk Road Medical Inc
CIK 0001397702
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001770767
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 9:58 PM ET
- Size
- 170.7 KB